Further research on CDKL5‐KO mice might also accelerate our understanding of the neurophysiological and molecular mechanisms that underlie REMS‐related OSA, with the potential of uncovering novel druggable targets (Alvente et al., 2023). The gene discussed is CDKL5; the disease is obstructive sleep apnea syndrome.